DE3880397D1 - Amphotericin b/cholesterolsulfat-zusammensetzung und -verfahren. - Google Patents

Amphotericin b/cholesterolsulfat-zusammensetzung und -verfahren.

Info

Publication number
DE3880397D1
DE3880397D1 DE8888902717T DE3880397T DE3880397D1 DE 3880397 D1 DE3880397 D1 DE 3880397D1 DE 8888902717 T DE8888902717 T DE 8888902717T DE 3880397 T DE3880397 T DE 3880397T DE 3880397 D1 DE3880397 D1 DE 3880397D1
Authority
DE
Germany
Prior art keywords
amphotericin
composition
molar ratio
aqueous suspension
particle sizes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888902717T
Other languages
English (en)
Other versions
DE3880397T2 (de
Inventor
Robert Abra
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intermune Inc
Original Assignee
Liposome Technology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Technology Inc filed Critical Liposome Technology Inc
Publication of DE3880397D1 publication Critical patent/DE3880397D1/de
Application granted granted Critical
Publication of DE3880397T2 publication Critical patent/DE3880397T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
DE8888902717T 1987-02-27 1988-02-26 Amphotericin b/cholesterolsulfat-zusammensetzung und -verfahren. Expired - Fee Related DE3880397T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/019,575 US4822777A (en) 1987-02-27 1987-02-27 Amphotericin B/cholesterol sulfate composition
PCT/US1988/000599 WO1988006450A1 (en) 1987-02-27 1988-02-26 Amphotericin b/cholesterol sulfate composition and method

Publications (2)

Publication Number Publication Date
DE3880397D1 true DE3880397D1 (de) 1993-05-27
DE3880397T2 DE3880397T2 (de) 1993-07-29

Family

ID=21793937

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888902717T Expired - Fee Related DE3880397T2 (de) 1987-02-27 1988-02-26 Amphotericin b/cholesterolsulfat-zusammensetzung und -verfahren.

Country Status (12)

Country Link
US (1) US4822777A (de)
EP (1) EP0303683B1 (de)
JP (1) JPH0610134B2 (de)
AT (1) ATE88348T1 (de)
AU (1) AU599779B2 (de)
CA (1) CA1336890C (de)
DE (1) DE3880397T2 (de)
DK (1) DK174871B1 (de)
FI (1) FI884889A (de)
HK (1) HK80596A (de)
NO (1) NO884741L (de)
WO (1) WO1988006450A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0825869B2 (ja) * 1987-02-09 1996-03-13 株式会社ビタミン研究所 抗腫瘍剤包埋リポソ−ム製剤
US5032582A (en) * 1987-02-27 1991-07-16 Liposome Technology, Inc. Method for treating fungal infections with amphotericin B/cholesterol sulfate composition
US5616334A (en) * 1987-03-05 1997-04-01 The Liposome Company, Inc. Low toxicity drug-lipid systems
US6406713B1 (en) 1987-03-05 2002-06-18 The Liposome Company, Inc. Methods of preparing low-toxicity drug-lipid complexes
US5194266A (en) * 1989-08-08 1993-03-16 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition and method
JP3074734B2 (ja) * 1990-11-16 2000-08-07 日本新薬株式会社 分散製剤
EP0599977A1 (de) * 1991-08-14 1994-06-08 SEQUUS PHARMACEUTICALS, INC. (a Delaware Corporation) Hiv behandlumg mit amphotericin b mit niedriger toxicitaet
US5264220A (en) * 1991-11-12 1993-11-23 Long David M Jr Method of extending the vascular dwell-time of particulate therapeutic and particulate diagnostic agents
WO1994008599A1 (en) * 1992-10-14 1994-04-28 The Regents Of The University Of Colorado Ion-pairing of drugs for improved efficacy and delivery
IT1283149B1 (it) * 1996-07-12 1998-04-07 Prodotti Antibiotici Spa Complessi di n'-dimetilaminoacetilpartricina a dimetilaminoetilamide, o suoi sali, e colesterol 3-solfato
US6613352B2 (en) 1999-04-13 2003-09-02 Universite De Montreal Low-rigidity liposomal formulation
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
AU2002245181B2 (en) 2000-12-21 2006-06-29 Nektar Therapeutics Pulmonary delivery of polyene antifungal agents
TWI252847B (en) * 2001-07-10 2006-04-11 Synta Pharmaceuticals Corp Synthesis of taxol enhancers
TWI297335B (en) 2001-07-10 2008-06-01 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI332943B (en) * 2001-07-10 2010-11-11 Synta Pharmaceuticals Corp Taxol enhancer compounds
TWI330079B (en) * 2003-01-15 2010-09-11 Synta Pharmaceuticals Corp Treatment for cancers
TWI249408B (en) * 2003-12-10 2006-02-21 Ind Tech Res Inst New antifungal formulation and manufacturing method thereof
KR101313027B1 (ko) 2004-06-23 2013-10-02 신타 파마슈티칼스 코프. 암 치료용 비스(티오-히드라지드 아미드) 염
NZ562572A (en) * 2005-04-15 2011-01-28 Synta Pharmaceuticals Corp Combination cancer therapy with BIS (thiohydrazide) amide compounds
US7678832B2 (en) 2005-08-16 2010-03-16 Synta Pharmaceuticals Corp. Bis(thio-hydrazide amide) formulation
WO2008024303A2 (en) 2006-08-21 2008-02-28 Synta Pharmaceuticals Corp. Compounds for treating proliferative disorders
WO2008027445A2 (en) * 2006-08-31 2008-03-06 Synta Pharmaceuticals Corp. Combination with bis(thiohydrazide amides) for treating cancer
US7645904B2 (en) * 2006-09-15 2010-01-12 Synta Pharmaceuticals Corp. Purification of bis(thiohydrazide amides)
US20100068251A1 (en) * 2006-10-10 2010-03-18 Jina Pharmaceuticals, Inc. Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
DE102015102210A1 (de) 2015-02-16 2016-08-18 Heraeus Medical Gmbh Antimykotischer polymerisierbarer Knochenzement und ein Verfahren zu seiner Herstellung
CA3053566A1 (en) * 2017-02-21 2018-08-30 Ico Therapeutics Inc. Solid oral formulations of amphotericin b
CN110305926B (zh) * 2019-05-27 2021-02-26 浙江工业大学 一种基于两性霉素b代谢途径的发酵方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002741A (en) * 1974-04-24 1977-01-11 Valter Osvaldovich Kulbakh Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method
US4468513A (en) * 1980-09-22 1984-08-28 Eli Lilly And Company 2'-N-Acylated and 2'-N-alkylated derivatives of 4-O-substituted-2-deoxystreptamine aminoglycosides
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4707470A (en) * 1985-05-17 1987-11-17 Smithkline Beckman Corporation Polyene antibiotic emulsion formulation

Also Published As

Publication number Publication date
US4822777A (en) 1989-04-18
HK80596A (en) 1996-05-17
JPH0610134B2 (ja) 1994-02-09
NO884741D0 (no) 1988-10-25
EP0303683A4 (de) 1989-12-28
ATE88348T1 (de) 1993-05-15
DK598388A (da) 1988-10-27
EP0303683A1 (de) 1989-02-22
FI884889A0 (fi) 1988-10-21
JPH01502270A (ja) 1989-08-10
DK598388D0 (da) 1988-10-27
EP0303683B1 (de) 1993-04-21
FI884889A (fi) 1988-10-21
NO884741L (no) 1988-10-25
CA1336890C (en) 1995-09-05
AU599779B2 (en) 1990-07-26
WO1988006450A1 (en) 1988-09-07
AU1482688A (en) 1988-09-26
DE3880397T2 (de) 1993-07-29
DK174871B1 (da) 2004-01-12

Similar Documents

Publication Publication Date Title
DE3880397D1 (de) Amphotericin b/cholesterolsulfat-zusammensetzung und -verfahren.
DK0808156T3 (da) Præparater omfattende nanopartikler af NSAID
CA2307693A1 (en) Disposable body wastes absorbent article
DE3583799D1 (de) Feste zubereitung mit langsamer freisetzung.
MY131440A (en) Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
ES2078551T3 (es) Medicamentos en aerosol.
EP0156924A4 (de) Chemisch aktive zusammensetzung ferro-ionen enthaltend.
AU555952B2 (en) Collagen implant containing active ingredient for implantation in bones
IL98258A0 (en) Composition for treating impotence containing doxazosin,amlodipine,or u.k.52,046
ATE179590T1 (de) Feste kosmetische präparate
EP0556394A4 (de) Lyophilisierte zubereitung sowie deren herstellung.
CA2039773A1 (fr) Composition cosmetique ou dermo-pharmaceutique aqueuse contenant en suspension des spheroides hydrates d'une substance lipidique hydrophile
EP0824152A3 (de) Mikrobielle Herstellung von Vitamin B12 sowie Herstellung und Verwendung von Zusammensetzungen die Vitamin B12 in hohen Konzentrationen enthalten
ES2141486T3 (es) Fertilizante y procedimiento de preparacion del mismo.
SE8700137D0 (sv) Diuretisk komposition
MY115429A (en) Fenbendazole formulations
AU4150489A (en) Micronised drug formulation
GR860329B (en) Reagent for the dosage of antibodies against bacteric toxines by hemaglutination method for preparation and application thereof
DE3687838D1 (de) Deodorant-bettmaterial.
IE800344L (en) Anti-perspirant compositions
EP0349589A4 (de) Pharmakologisch aktive cholinerge zubereitungen und verfahren zur herstellung und deren verwendung zur behandlung von krankheiten.
SE8401824L (sv) Pulver avsett for framstellning av mjukmagnetiska produkter
MX174642B (es) Formulaciones farmaceuticas
IT226149Z2 (it) " una busta almeno parzialmente trasparente, da impiegare nelle autovetture per la esposizione di documenti ed altro, e per impieghi equivalenti " .
MX9709011A (es) Composicion de vacuna que comprende fosfato de poliribosilribitol y su procedimiento de fabricacion.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: INTERMUNE, INC. (N.D.GES.D. STAATES DELAWARE), BRI

8339 Ceased/non-payment of the annual fee